Press Release | Tue Feb 19, 2013 7:00am EST

GSK and Theravance Announce FDA Acceptance of New Drug Application (NDA) Submission in the US for ANORO ELLIPTA(TM) for COPD

* Reuters is not responsible for the content in this press release.